medigraphic.com
ISSN 1726-6718 (Electronic)
Revista Cubana de Anestesiología y Reanimación

2018, Number 3

<< Back Next >>

Revista Cubana de Anestesiología y Reanimación 2018; 17 (3)

Neuromuscular blocking drugs in continuous infusion in total intravenous general anesthesia

Cordero EI, García ML

Language: Spanish
References: 27
Page: 1-11
PDF size: 105.04 Kb.


ABSTRACT

Introduction: The administration of anesthetic agents intravenously started a new modality that involved the administration of anesthetics in the form of continuous infusions.
Objective: To update the information on the function of neuromuscular blocking drugs when administered in continuous infusion in total intravenous general anesthesia.
Development: Neuromuscular blocking drugs can be administered in continuous infusion to maintain a stable plasma concentration and achieve adequate relaxation of the patient during the surgical procedure, as well as a faster and safer spontaneous recovery, based on the action onset of the drug used, but fundamentally on its maximum effect. Despite this, it is important to administer an initial loading dose that must range from 2 to 3 DE 95 (effective dose to decrease the response to the stimulus in 95% of its initial value) and continue with the administration in continuous infusion as part of the maintenance of anesthesia.
Conclusions: Regardless the different criteria among authors, most agree that continuous infusions are effective in maintaining greater blood stability and, therefore, lower doses of neuromuscular blocking drugs, shorter real reversal times and fewer adverse effects.


REFERENCES

  1. White P. Clinical uses of intravenous anesthetic an analgesic infusion. Anesth & Analg. 1989;68:161-71.

  2. Muñoz-Cuevas JH. TIVA: Papel en la anestesia moderna. Rev Mex Anest. 2006;29(Supl 1):141-47.

  3. Pérez Carbonell A. Bloqueantes neuromusculares. Infusión o Bolos? En: Carrillo Esper R. Bloqueantes Neuromusculares. Clin Mex Anest. Ed Alfil. México. 2012. pp. 57-64.

  4. Pollard BJ. The role of muscle relaxants in total intravenous anaesthesia. Acta Anaesthesiol Scand Supp l. 1995;106:58-61.

  5. Ali HH. Clinical Pharmacologic of mivacurium cloride infusion. Comparison with vecuronium and atracurium. Br J Anaesth. 1988;61:541-46.

  6. Rigg JD, Wilson AC, Pollard BJ. Mivacurium or vecuronium for muscular relaxation in day-case surgery. Eur J Anaesthesiol. 1997;14:630-34.

  7. Mirakhur RK, McCourt KC, Kumar N. Use of intermediate acting muscle relaxants by infusion: the future. Acta Anaesthesiol Belg. 1997;48:29-34.

  8. Sterling E, Shane Winstead P, Fahy BG. Guide to neuromuscular blockers agent. Anesthesioly News special edition. Macmahone: Publish New York; 2007. p. 1-30.

  9. Sepúlveda PO. ¿Qué aprendimos de los modelos de propofol? Rev Chil Anest. 2011;40(1):66-76.

  10. Cordero Escobar I, Granell Gil M, Palanca San Francisco JM. Eficacia clínica de cuatro relajantes neuromusculares no despolarizantes en infusión continua. Rev Mex Anest. 2002;25(1):37-40.

  11. Naguib M, Lien CA. Pharmacology of muscle relaxants and their antagonists. In: Miller RD. Anesthesia, 6th ed. New York: Churchill Livingstone; 2005. p. 481-572.

  12. Ito S, Nagata O, Ozaki M. Estimated blood concentration of rocuronium administrated by continuous infusion to maintain an appropriate neuromuscular blockade under ropofol anesthesia. Masui. 2010;59(1):82-6.

  13. Saralegui J, Castañola D, Olazábal R, Pastorino M, Arén L. Rocuronio en infusión continua para cirugía laparoscópica ginecológica: evaluación clínica y electromiográfica. Anest Analg Reanim. 1999 [citado 2 ago 2012];15(2).

  14. Fernández P, Andruskevicius M, Castañola D, Cristiani F. ¿Es necesario utilizar relajantes musculares en infusión continua durante la anestesia en pacientes sometidos a cirugía cardiaca?. Anest Analg Reanim. 2011 [citado 2 ago 2012];24:3. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S0255812220110001000 03&lng=es&nrm=iso

  15. Cammu G, Cardinael S, Lahousse S, Eecke GV, Coddens J, Foubert L, et al. Muscle relaxation does not influence venous oxygen saturation during cardiopulmonary bypass. J Clin Anesth. 2007;19(9):105-9.

  16. Heier T, Caldwell JE. Impact of hypothermia on the response to neuromuscular blocking drugs. Anesthesiology. 2006;104(5):1070-80.

  17. Jurado LV, Gulbis BE. Continuous infusion versus intermittent bolus dosing of vecuronium in patients receiving therapeutic hypothermia after sudden cardiac arrest. Pharmacotherapy. 2011;31(12):1250-6.

  18. Hemmerling TM, Russo G, Bracco D. Neuromuscular blockade in cardiac surgery: an update for clinicians. Ann Card Anaesth. 2008;11(2):80-90.

  19. Sepúlveda PO. Conceptos farmacocinéticas e TIVA. 2000 [citado 17 sep 2012]. Disponible en: http://www.medens.com/UploadedMediaFiles/M1L3.3%20Farmacología%20II.pdf

  20. Cordero EI. Reversión de los relajantes musculares. En: Cordero EI. Los relajantes musculares en la clínica anestesiológica. La Habana: ECIMED; 2010. p 195-99.

  21. Miller DR, Wherrett C, Hull K , Watson J, Legault S. Cumulation characteristics of cisatracurium and rocuronium during continuous infusion. Can J Anaesth. 2000;47(10):943-9.

  22. Navarrete Zuazo V. Monitorización de la profundidad anestésica. 2012 [citado 2 ago 2012]. Disponible en: http://files.sld.cu/anestesiologia/files/2012/07/monitorizacion-de-la-profundidadanestesica- editorial1.pdf

  23. Carrillo Esper R, Carrillo-Córdova LD, Carrillo-Córdova JR. Despertar transoperatorio y análisis biespectral. Su impacto en la práctica anestesiológica. Rev Mex Anest. 2007;30(2):97-104.

  24. White PF, Tufanogullari B, Sacan O, Pavlin EG, Viegas OJ, Minkowitz HS, et al. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex. Anesthesia & Analgesia. 2009;108(3):846-51.

  25. Cordero Escobar I, Rey Martínez B, Company Teuler R, Pérez Carbonell A. Reversión del rocuronio con sugammadex en pacientes con procederes de larga duración. Presentación de dos casos. Rev Cubana Anest Rean. 2011 [citado 2 ago 2012];10(2). Disponible en: http://bvs.sld.cu/revistas/scar/indice.html

  26. Paton F, Paulden M, Chambers D, Heirs M, Duffy S, Hunter JM, et al. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation. Br J Anaesth. 2010;105(5):558-67.

  27. Cordero Escobar I, Pérez Carbonell A, Rey Martínez B, Company Teuler R, Díaz León I. Uso del sugammadex para la reversión del bloqueo neuromuscular de larga duración con rocuronio: bolos vs infusión continua. Rev Argentina Anest. 2013;71(1):54-60.




2020     |     www.medigraphic.com